The numbers are staggering by any standard. A 133.7 percent gain in 30 days. A stock trading 524 percent above its 52-week low. A volatility reading of 517 percent that makes even the most seasoned traders blink twice. Moderna has delivered one of the most extraordinary momentum runs in recent S&P 500 history — and […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.